Sir Jonathan Symonds
Sir Jonathan Symonds serves as the Chairman of GlaxoSmithKline, a major pharmaceutical company, where he is instrumental in overseeing the company's initiatives to improve health outcomes through innovative treatments.
Global Media Ratings
Countries Mentioned
| Country | Mentions | Sentiment | Dominance | + Persistence | x Population | = Reach | x GDP (millions) | = Power |
|---|---|---|---|---|---|---|---|---|
| United Arab Emirates | 1 | 8.00 | 0.05% | +0% | 9,890,400 | 5,255 | $430,000 | 228$ |
| Totals | 1 | 9,890,400 | 5,255 | $430,000 | 228$ |
Interactive World Map
Each country's color is based on "Mentions" from the table above.
Recent Mentions
United Arab Emirates:
Sir Jonathan Symonds highlighted GlaxoSmithKline's commitment to enhancing health security through strategic partnerships.
8
United Arab Emirates:
Sir Jonathan Symonds is the Chair of the Board of GlaxoSmithKline.
7
United Arab Emirates:
Sir Jonathan Symonds is the Chair of the Board of GlaxoSmithKline.
7